期刊文献+

来曲唑促排卵的个体化应用 被引量:7

Individual application of letrozole for ovulation induction
原文传递
导出
摘要 目的:探讨来曲唑(LE)促排卵的个体化用药方法。方法:①收集近期不孕症门诊Ⅱ型排卵障碍患者78例、185个促排卵周期,其中多囊卵巢综合征(PCOS)152周期,其他排卵障碍33周期。②以诊断为依据选择LE启动剂量为2.5 mg和5.0 mg;适时添加HMG。③起始用药时间多于月经第5天开始,超过月经5天以上者,在内膜厚度<6 mm且处于增生期(A型)的前提下直接启动;用药天数以5天为准,根据卵巢反应性适度增减。结果:①153(82.3%)周期使用5.0 mg,32(17.7%)周期使用2.5 mg;PCOS 135(88.8%)周期使用5.0 mg,17(11.2%)周期使用2.5 mg;47(25.4%)周期辅以HMG。②月经周期3~5天启动163(88.1%)周期;6~8天启动17(9.2%)周期;9天以上启动5(2.7%)周期;用药3~5天171(92.4%)周期,6~7天13(7.0%)周期,8~9天1(0.6%)周期。③11周期促排卵失败,174周期成功,成功率94.1%;62例成功妊娠,累计周期妊娠率79.5%,每排卵周期妊娠率33.5%;成功妊娠者平均促排卵2.4周期;每周期平均排卵数1.2个;双胎妊娠1例,无中度以上卵巢过激综合征(OHSS)。结论:通过以诊断为依据选择合适的剂量并适时辅以HMG、灵活掌握启动时间和用药天数等个体化用药方法,能明显提高LE的促排卵效率。 To explore the method of individual application of letrozole for ovulation inductiorL Methods: A total of 78 patients (185 cycles) with type I1 ovulation barrier were collected from infertile outpatient, including 152 cycles of polycystic ovary syndrome (PCOS) and 33 cycles of other ovulation barriers. The start doses of letrozole were designed at 2. 5 mg and 5.0 mg according to diagnostic criterion; human gonadotropin (HMG) was added in due time. The start time of letrozole application was on the fifth day of menstruation, for the patients more than five days of menstruation, the treatment started on condition of thickness of endometrium 〈 6 mm and during proliferative phase; five days were designed as a course of treatment, then the time was increased and decreased appropriately according to o- varian reaction. Results: The start dose of 153 cycles (82. 3% ) was 5.0 rag, and the start dose of 32 cycles ( 17.7% ) was 2. 5 mg. The start dose of 135 PCOS cycles (88. 8% ) was 5.0 rag, and the start dose of 17 PCOS cycles ( 11.2% ) was 2. 5 rng. 47 cycles (25.4%) were supplemented with HMG. 163 cycles ( 88. 1% ) started at 3 - 5 days of menstruation; 17 cycles (9.2%) started at 6 - 8 days of men- struation; 5 cycles (2. 7% ) started at more than 9 days of menstruation; 171 cycles (92.4%) were treated for 3 -5 days, 13 cycles (7.0%) were treated for 6 -7 days, one cycle (0. 6% ) was treated for 8 -9 days. Eleven cycles failed for ovulation induction, 174 cycles succeeded, the success rate was 94. 1%. A total of 62 women got pregnancy successfully, the accumulative cycle pregnancy rate was 79. 5%, the pregnancy rate of per ovulatory cycle was 33.5% ; the mean cycles of ovulation induction among the pregnant women was 2. 4 cycles. The mean number of ovulation per cycle was 1.2 ; one woman got twin pregnancy, no more than moderate ovarian hyperstimulation syndrome (OHSS) occurred. Conclusion: Choosing appropriate dose according to diagnostic criterion and auxiliary application of HMG, grasping individual application, including the start time and application time flexibly, can improve the efficacy of ovulation induction with letrozole.
出处 《中国妇幼保健》 CAS 北大核心 2012年第9期1356-1359,共4页 Maternal and Child Health Care of China
关键词 不孕症 来曲唑 促排卵 Infertility Letrozole Ovulation induction
  • 相关文献

参考文献11

  • 1Jocabson N. Lie and Jordan Triple Systems [J]. Amer J Math, 1948, 71: 148 - 170.
  • 2Hophins N. On the Derivation Algebra of Lie Module Triple Systems [J]. J Algebra, 1987, 111:520 -527.
  • 3Lister W G. A Struction Theory of Lie Triple Systems [J]. Trans Amer Math Soc, 1952, 72:217 - 242.
  • 4Hophins N. Nilpotent Ideals in Lie and Anti-Lie Triple Systems [J]. J Algebra, 1995, 178: 480-494.
  • 5Yang MY,Rajamahendran R.Morphological and biochemical identifica-tion of apoptosis in small,medium,and large bovine follicle and the effects of follicle-stimulating hormone and insulin-like growth factor-I on spontaneous apoptosis in cultured bovine granulose cell(J).Biol Reprod,2000,62(5):1209.
  • 6SHI Yi-qian, MENG Dao-ji. On Derivations and Automorphism Group of Lie Triple Systems [J]. J Nankai University,2002, 35: 32 - 37.
  • 7George F Leger, Eugene M Luks. Generalized Derivation of Lie Algebras [J]. J Algebra, 2000, 228:165 - 203.
  • 8Fatemi HM,Popovic-Todorovic B,Donoso P et al.Luteal phase oes-tradiol suppression by letrozole:a pilot study in oocyte donors(J).Re-prod Biomed Online,2008,17(3):307.
  • 9Badawy A,Metwally M,Fawzy M.Randomized controlled trial of threedoses of letrozole for ovulation induction in patients with unexplained in-fertility(J).Reprod Biomed Online,2007,14(5):559.
  • 10Noriega-Portella L,Noriega-Hoces L,Delgado A et al.Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonado-tropins in women undergoing intrauterine insemination(J).Fertil Steril,2008,90(5):1818.

二级参考文献35

  • 1张琼,李艳萍.来曲唑治疗克罗米酚促排卵无效三例分析[J].生殖医学杂志,2005,14(4):239-241. 被引量:19
  • 2王颖,陈咏健,李美芝,杨池逊,王振红,姜颜彬.促排卵周期PCOS妇女子宫内膜纤维粘连蛋白及层粘连蛋白的表达[J].生殖与避孕,2005,25(12):724-731. 被引量:5
  • 3Sherry G, Krishnamurthy H, Krishnamurthy HN, et al. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol, 1997,61(3-6):157-66.
  • 4Casper RF. Letrozole: ovulation or superovulation ? Fertil Steril, 2003, 80(6): 1335-7.
  • 5Mitwally M & Casper R. The aromatase inhibitor, letrozole:a promising alternative for clomiphene citrate for induction of ovulation. Fertil Steril, 2000, 4(Suppl I): S35.
  • 6Healey S, Tan SL, Tulandi T, et al. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril, 2003, 80(6): 1325-9.
  • 7Fisher SA, Reid RL, Vuget DA, et al. A randomized doubleblind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril, 2002, 78(2):280-5.
  • 8Mitwally MF & Casper RF. Aromatase inhibiton improves ovarian response to follicle-stimulation hormone in poor responders. Fertil Steril, 2002, 77(4):776-80.
  • 9Mitwally MF & Casper RF. Aromatase inhibiton reduces gonadotrophin dose required for controlledovarian stimulation in women with unexplained infertility. Hum Reprod,2003, 18(8):1 588-97.
  • 10Dickey RP & Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update, 1996, 2(6):483- 506.

共引文献17

同被引文献59

  • 1Boudhraa K,Jellouli MA.Indication of mefformin in the management of hormonal dysfunction secondary to polycystic ovarian syndrome:prospective comparative study of 63 cases[J].Tunis Med,2010,88(5):335-340.
  • 2Tehraninejad ES,Nasiri R,Rashidi B,et al.Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOS patients[J].Arch Gynecol Obstet,2010,282(3):319-325.
  • 3Heijnen EM,Eijkemans M J,De Klerk C,et al.A mild treatment strategy for invitro fertilization:a randomised no inferiority trial[J].Lancet,2007,369 (9563):743-749.
  • 4Boyle J,Teede HJ.Polycystic ovary syndrome-An update[J].Aust Fam Physician,2012,41 (10):752-756.
  • 5Bedaiwy MA,Mousa NA,Esfandiari N,et al.Follicular phase dynamics with combined aromatase inhibitor and follicle stimulating hormone treatment[J].J Clin Endocrinal Metab,2007,92(3):825-833.
  • 6Ray Chaudhuri A,Chatterjee S.Frozen embryo transfer:the present practice and beyond[J].J Basic Clin Physiol Phannacol,2013,22:1-6.
  • 7Mitwally M F. Casper R F, Diamond M P.The role of aromatase ir2qibitois in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment[J].Reprod Biol Endocrinol, 2005, 4(3) : 54.
  • 8Dehbashi S, Parasanezhad M E, Alborzi S, et al.Effect of clomipphene citrate on endometrium thickness and echogenic patterns[J].Int J Gy-necol Obstet, 2003, 80(1): 49-53.
  • 9Cortinez A, De Carvalho I, Vantman D, et al.Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovu|atoryinfertilepatients[J].FertilSteril, 2005, 83(1): 110-115.
  • 10Usama M,Ahmed M.Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination:A randomized controlled tria [J]. Reprod Bid Endocrinol, 2011,21 (9) : 84-90.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部